With a budget of up to $20m, the collaboration will establish scalable, rapid manufacturing for recombinant-protein vaccines.

In the last few weeks, Health Canada issued several decisions concerning biologics. On October 17, Health Canada approved, via a Notice of Compliance, Biocon Biologics Ltd.’s YESINTEK (ustekinumab ...

Oncodermatology is evolving with nonsurgical approaches and immune checkpoint inhibitors, improving outcomes in aggressive ...

Biologics are used for people with severe eczema when other treatments don't work. Dupixent was the first biologic approved for eczema in 2017. Different biologics target different interleukins, which ...

Please provide your email address to receive an email when new articles are posted on . Biologic therapies are underutilized in non-white populations. By identifying barriers to specific biologic ...

Biologics targeting IL-12, IL-23, or IL-17 are linked to lower infection risk in older adults with psoriatic disease compared to other systemic treatments. The study utilized Ontario's health ...

Biologics, with their precision targeting, expand treatment options for a multitude of diseases - from cancer to autoimmune disorders. In 2023 alone, 10 antibody therapeutics received their first ...

The primary finding from the clinical trials for the COPD biologics is reduced annual exacerbations by 30% (BOREAS trial) and 34% (NOTUS trial). In the BOREAS trial, in addition to reduced ...

Over the last decade-plus, China has become a booming biopharma innovator thanks in part to a big boost from its government. Now the question is, can its neighbor to the south, India, make a similar ...

DE SOTO, Kan. (KCTV) - Another major economic project is in the works for west Johnson County, Kansas. Merck Animal Health announced on Thursday morning that it plans to invest $895 million in the ...